Gut Health and the Role of Probiotics

GASTROINTESTINAL
HEALTH BEYOND THE
GLUTEN-FREE DIET:
Probiotics and Other Therapy
Jacqueline Wolf, M.D.
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
I have no industry or commercial
interests to declare that have any
application to my presentation
AT THE END OF THIS
PRESENTATION YOU SHOULD:
Understand some of the roles of intestinal
bacteria and how they are altered in irritable
bowel disease(IBS) and celiac disease (CD).
Understand how probiotics (healthy organisms)
may be of benefit in IBS and CD
Understand what other non-traditional therapies
may be of benefit for gastrointestinal symptoms
in IBS and possibly celiac disease
What is normal gut function?
Bowel movements 2x/day to 2-3x/week are normal
Stool form varies from person to person. In general the
stool is usually well formed.
Gas occurs in everyone. The amount depends on what
you eat (500mL to 1500mL per day)
Medications including herbs and over-the-counter
medications can sometimes cause constipation, diarrhea
or heartburn.
Most people have rare heartburn
B
A
C
T
E
R
I
A
 
I
N
 
Y
O
U
R
 
G
U
T
1-2 kilograms  x  body weight
Cellular content > 10 fold higher than cells in
the body (100,000,000,000,000)
Bacterial microbiome (genes) 100 fold >
human genome
Collective metabolic activity > liver activity
Likely > 1000 different bacterial species in
the gut
Inflamm. Bowel Dis 2004; Science  2005; 308:1635-38; Physiol Rev 2010;90:859-904;
Gastroenterology 2014;146:1449-58
B
A
C
T
E
R
I
A
 
I
N
 
Y
O
U
R
 
G
U
T
W
h
a
t
 
d
o
 
t
h
e
y
 
d
o
?
Produce carbohydrate-active enzymes that digest
carbohydrates
Break down protein to their component amino acids and then
participate in their change to biogenic amines (compounds
with another effect on the body), to immunomodulator
compounds and to signaling compounds.
Produce antimicrobial peptides or bacteriocins that may keep
harmful organisms at bay.
Make vitamins such as folate and Vitamin B12
Participate in and stimulate the development and function of
the immune response
 
 
Inflamm. Bowel Dis 2004; Science  2005; 308:1635-38; Physiol Rev 2010;90:859-904;
 
Gastroenterology 2014;146:1449-58
B
A
C
T
E
R
I
A
 
I
N
 
Y
O
U
R
 
G
U
T
ESOPHAGUS 
(0-10
2
)
Limited in diversity
Dominated by 
Streptococcus
Increased diversity associated with chronic inflammation and dysplasia
STOMACH 
(0-10
2
)
Limited in diversity
Helicobacter pylori limits diversity
Without 
H. pylori 
dominated by 
Streptococcus
SMALL INTESTINE (
10
2
 
duodenum, jejunum; 10
7
-10
8 
 distal ileum)
Dominated by 
Streptococcus 
in duodenum and jejunum
Increased number and diversity as you travel down the small bowel to
the ileum
Gastroenterology 2014;146:1449-1458
B
A
C
T
E
R
I
A
 
I
N
 
Y
O
U
R
 
G
U
T
LARGE INTESTINE (COLON) 
(10
11
-10
12
)
Dominated by phylum Firmicutes (includes Lactobacilli)
and phylum Bacteroidetes
Next most common Actinobacteria (includes
Bifidobacteria) and Verrucomicrobia
Diet can change the microbiome
Ratio of Firmicutes: Bacteroidetes may determine
predisposition to obesity
Proteobacteria small proportion in normal individuals but
may be increased in people with GI diseases
Gastroenterology 2014;146:1449-1458
CELIAC DISEASE AND IRRITABLE
BOWEL SYNDROME
What is the possible connection?
Symptoms of celiac disease and IBS may overlap
People with celiac disease may also have IBS
Studies show a 4.5% prevalence of celiac disease in
people with IBS diagnosed by Rome I or II criteria
Systemic review and meta-analysis showed 4 fold
increase in IBS compared to non-IBS populations of
celiac disease with positive serology and biopsies
3% of people with a clinical presentation of IBS
subsequently diagnosed with celiac disease.
Reviewed in  Verdu EF et al. Am J Gastroenterol 2009. 104(6):1587-94  
IRRITABLE BOWEL SYNDROME
Can present as:
1.
Diarrhea predominant (IBS-D)
2.
Constipation predominant (IBS-C)
3.
Mixed (alternating pattern of diarrhea and
constipation)
IRRITABLE BOWEL SYNDROME
Criteria for Diagnosis
The microbiome (gut bacteria
composition) is altered in IBS
Bifidobacterium--
decreased
Lactobacillus-
inconsistent findings with
some studies showing a decrease and
others showing an increase
The microbiome (gut bacteria composition) is
altered in Celiac Disease (CD)
Reduced concentration of 
Bifidobacterium 
spp. in the
feces of untreated CD patients and in both active and
nonactive CD as compared to healthy people
Decreased numbers of 
Bifidobacterium 
spp. and
increased numbers of 
Bacteroides 
spp. In duodenal
biopsies of untreated CD
Treated CD patients with persistent symptoms vs those
without symptoms had higher relative abundance of
Proteobacteria
 and lower numbers of 
Bacteroidetes 
and
Firmicutes
 with an overall reduction in microbial
richness
J Clin Gastroenterol 2013:47;101-103; j Clin Pathol 2009;62:264-9; Am J Gastroenterol 2014:109;1933-1941
W
H
A
T
 
A
R
E
 
P
R
O
B
I
O
T
I
C
S
Probiotics are living organisms contained
in foods, such as yoghurt, and in other
supplements in the form of capsules,
powder or tablets, which confer a health
benefit when administered in adequate
amounts.
 
Morelli L. J Clin Gastroenterol 2012;46:S1-S2
S
o
m
e
 
P
r
o
b
i
o
t
i
c
s
 
o
n
 
t
h
e
 
M
a
r
k
e
t
L.
 
casei
L. casei 
Shirota
L. johnsonii
Some Probiotics on the Market
L. casei
L.
 
reuteri
L. rhamnosus
 GG
B. lactis
 Bb12
PROBIOTICS IN IBS
Mechanisms of action
Change gut bacterial composition
Potentially return abnormal gut flora to normal
Competitive interactions with pathogens
Produce chemical products, that are toxic to pathogenic
bacteria or viruses.
Reinforce the mucosal barrier
Inhibit the movement of bacteria across the gut wall
Produce neurotransmitters that influence the motility and
sensation of the gut
Produce cytokines, neuroactive peptides, fatty acids, gas
and other substances.
Reviewed in Gastroenterology 2014; 146 (6
)
Probiotics Effective in IBS
Probiotic
  
   Targeted Symptom relief
  
  Sample Size         Weeks
 
    
                 
   
Bifidobacterium 
 
  
Reduced discomfort and bloating
 
        274
  
  3/6
animalis
  
  
in constipation-predominant IBS
Bifidobacterium 
 
  
Reduced abdominal pain and 
 
        362
  
   4
infantis 35624
 
  
other IBS symptoms
Bifidobacterium 
 
  
Alleviated global IBS, improved 
 
        122
  
   4
bifidum MIMBb75      
IBS symptoms and QOL
Escherichia coli 
 
  
Helped in patients with altered
 
        120
  
  12
Nissle
  
  
  
enteric microflora, for example,
  
  after gastroenterocolitis or use of
  
  antibiotics
Lactobacillus 
 
  
Improved abdominal pain and
 
        214
  
   4
plantarum 
299v
 
  bloating
    
Reviewed in 
S.S Magge & J.L Wolf . 
Women’s Health (
2013) 9(6), 1-11
   
Probiotics Effective in IBS
Probiotic
  
   Targeted Symptom relief
  
  Sample Size
 
Weeks
 
       
Saccharomyces 
 
  
Improved QOL, but not significantly
 
       67
  
    4
boulardii
  
  
in individual symptoms
Lactobacillus 
 
  
Improved bloating 
 
        
  
       60
  
    4
Acidophilus NCFM
 
Bifidobacterium 
 
 
Improved bloating
 
   
  
       60
  
    4
lactis 
Bi-07
      
 
Lactobacillus 
 
  
Reduced frequency and
 
       
 
       50
  
    6
Rhamnosus 
GG
 
 
  severity of abdominal pain in
  
  children
Lactobacillus 
 
 
Reduced abdominal pain
 
       
 
       40
  
    4
acidophilus
  
 
VSL
#3
 
 
 
Reduced flatulence and retarded
 
       48
  
   4/8
 
                colonic transit
   
Reviewed in S.S Magge & J.L Wolf . 
Women’s Health 
(2013) 9(6), 1-11
   
   
S.S Magge & J.L Wolf  Women’s Health (2013) 9(6), 1-11
PROBIOTICS IN CELIAC DISEASE
VSL#3 (but not 3 other probiotics) reduced the toxicity of
gluten when used in a fermentation process
Bifidobacterial strains produced less toxic gliadin
peptides 
in vitro
Saccharomyces boulardii 
KK1 degraded part of the α-
gliadin. In gluten sensitized mice KK1 decreased the IgA
transporter (CD71) and improved the small bowel
abnormalities and local cytokines (accelerated hair loss
with DC412)
Bifidobacterium infantis 
Natren Live Start Super Strain
did not improve intestinal permeability, but did improve
Gastrointestinal Symptoms and a macrophage
inflammatory cytokine, but not other inflammatory
markers (# 12 CD; 10 controls)
Biochimica et Biophysica Acta 2006; 1762:80-93;
 Laboratory Investigation
 2012;
 
92:625-635
J Clin
Gastroenterol 2013:47;101-103; 
Mouse Model for Celiac Disease:
Treatment with probiotics
G-mice
D1
D7
D37
Gluten Diet (G+)
Every Day
Every 3
days
Sacrifice
Oral delivery of KK1
or DC205 or DC412
or PBS
Laboratory Investigation
 2012;
 
92:625-635
Mouse Model for Celiac Disease:
Treatment with probiotics
 G-    No gluten
 G+   With gluten
KK1   Saccharomyces boulardii
DC205, DC412 Lactobacillus paracasei
Villous:crypt
ratio
Laboratory Investigation
 2012;
 
92:625-635
*
*
*
*
#
*P<0.05 G + to G-,
#
P<0.05 KK1 to G+
Mouse Model for Celiac Disease:
Treatment with probiotics
Positive Cell number
Laboratory Investigation
 2012;
 
92:625-635
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
#
#
#
*P<0.05 G + to G-,
#
P<0.05 KK1 to G+
Treatment of Celiac Disease with
Bifidobacterium infantis
  
     Probiotic Arm (#)
  
                           Placebo Arm (#)
Syndromes
 
Baseline
  
Final
  
Baseline
  
Final
Indigestion
 
4.3 (3.4-5.3)
 
2.9 (2.1-3.7)*
 
4.0 (2.7-5.3)
 
3.6 (2.6-
4.6)
Diarrhea
  
3.3 (2.0-4.7)
 
2.7 (1.6-3.8)
 
2.9 (1.7-4.0)
 
1.6 (0.9-
2.3)*
Constipation
 
3.6 (2.2-5.0)
 
2.5 (1.4-3.5)^
 
2.7 (1.5-3.9)
 
2.4 (1.0-
3.7)
GERD
   
Not Significant
   
Not Significant
Abdominal Pain
  
Not Significant
   
Not Significant
Composite Score
Final/baseline ratio
  
Not Significant
   
Not Significant
     *P <0.005, ^P<0.05
  
E. Smecuol et al. 
J Clin Gastroenterol 
2013:47;139-147
Herbal medicines shown to be effective in IBS
Herbal medicines use plant extracts to treat different symptoms and
diseases. For effective results the herbs can be used either
individually, as a mixture of different herbs or in combination with
western medication.
Herbal Medicine
  
Targeted Symptom Relief
  
      
Length of
Study (Wks)
Chinese Herbs
  
 Improved IBS global symptoms
  
16
Padma Lax
  
 Improved constipation, abdominal pain, 
  
12
   
 abdominal distension and flatulence
Tong Xie Yao Fang
  
 Decrease in activated mast cells present in 
 
 4
   
 IBS
STW5,STW5II,placebo
 
Reduced abdominal pain
 
and IBS symptoms
 
 4
STW 5/placebo (315)
 
Decreased gastrointestinal symptom score 
 
 8
  
  
Reviewed in 
S.S Magge and J.L Wolf. 
Women’s Health 
(2013) 9(6), 1-11
    
The truth about gas…
When carbohydrates and fat within our food
aren’t broken down by the enzymes our bodies
make and are not absorbed by the intestines
into our bodies, bacteria found in our bowels
metabolize them and form gas as a by-product.
Depending on the type of bacteria residing in
your gut and what food you eat, different gases
and therefore different odors will be released.
Gas is often a byproduct of what we eat.
TREATMENT OF GAS AND
BLOATING
Peppermint oil
Simethicone-changes the surface
characteristics of the gas bubbles making
it easier to pass
Activated charcoal-adsorbs the gas.
However, it can interfere with medication
absorption
Peppermint Oil:
Treatment for Gas and Bloating
A cross between watermint and spearmint
Menthol is thought to be the active component causing
calcium-channel blocking activity
The blockage of calcium flow into smooth muscle in the
intestine decreases muscle contractions thereby reducing pain
Adverse effects include heartburn, skin rash, perianal burning,
bradycardia and muscle tremor.
Reviewed in S.S Magge and J.L Wolf 
.Women’s Health (
2013) 9(6), 1-11
Peppermint Oil in IBS
Study
  
                Targeted Relief Symptom
   
       Sample
Size
Meta-analysis of 8
 
 Significant improvement of IBS symptoms
Trials-5 dble blind
 
        
 
Randomized,
 
                Reduced abdominal distension,,
  
        110
Double-blind placebo           
stool frequency
 and flatulence
Controlled study-4wks
 
2007 Double-blind study 
 
 75%PO vs 38%PL
   
         57IBS
4 weeks
   
 >50% reduction in IBS symptoms
   
   
Reviewed in S.S Magge and J.L Wolf .
Women’s Health (
2013) 9(6), 1-11
Acupuncture not shown to be effective in IBS
Acupuncture is based on a life force 
qi
 that runs through the body in channels
called meridians
Disruptions in qi result in disease processes, which can be corrected at the exact
anatomical locations using acupuncture
Study
  
                       Results
   
       Sample Size/wks
   
Real vs Sham  acupuncture       No significant difference 
  
230/3 wks
vs no treatment
  
         in IBS symptoms sham vs real
   
         but better than no treatment
 
   
          
     
Cochran review-17 random-        Many poor quality. 
   
1806/variable
Ized clinical trials
  
         Variable results.Same as
   
         Bifidobacteria, psychotherapy
    
 
Reviewed in S. S Magge et al. Women’s Health 2013. 9(6):1-11
SUMMARY
The gut contains numerous bacteria
The bacteria differ in people with Irritable Bowel Syndrome
(IBS) and Celiac disease (CD) from healthy individuals
without those conditions.
Some probiotics have been shown to improve symptoms of
patients with IBS
Some probiotics make gluten less toxic to patients with CD,
but to date in people in contrast to animals there are no
trials showing benefit.
Some herbal compounds help IBS patients
Peppermint oil may help bloating and gas
Acupuncture has not shown benefit in IBS
Slide Note
Embed
Share

Gut health plays a crucial role in overall well-being, with a diverse community of bacteria in the gut contributing to digestion, immunity, and metabolic processes. Probiotics, beneficial microorganisms, can help maintain a healthy gut environment. This presentation by Dr. Jacqueline Wolf explores the significance of intestinal bacteria in conditions like Irritable Bowel Syndrome (IBS) and Celiac Disease (CD), highlighting the potential benefits of probiotics and other non-traditional therapies in managing gastrointestinal symptoms.

  • Gut Health
  • Probiotics
  • Intestinal Bacteria
  • Digestive Health
  • Irritable Bowel Syndrome

Uploaded on Sep 16, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. GASTROINTESTINAL HEALTH BEYOND THE GLUTEN-FREE DIET: Probiotics and Other Therapy Jacqueline Wolf, M.D. Associate Professor of Medicine Beth Israel Deaconess Medical Center

  2. I have no industry or commercial interests to declare that have any application to my presentation

  3. AT THE END OF THIS PRESENTATION YOU SHOULD: Understand some of the roles of intestinal bacteria and how they are altered in irritable bowel disease(IBS) and celiac disease (CD). Understand how probiotics (healthy organisms) may be of benefit in IBS and CD Understand what other non-traditional therapies may be of benefit for gastrointestinal symptoms in IBS and possibly celiac disease

  4. What is normal gut function? Bowel movements 2x/day to 2-3x/week are normal Stool form varies from person to person. In general the stool is usually well formed. Gas occurs in everyone. The amount depends on what you eat (500mL to 1500mL per day) Medications including herbs and over-the-counter medications can sometimes cause constipation, diarrhea or heartburn. Most people have rare heartburn

  5. BACTERIA IN YOUR GUT 1-2 kilograms x body weight Cellular content > 10 fold higher than cells in the body (100,000,000,000,000) Bacterial microbiome (genes) 100 fold > human genome Collective metabolic activity > liver activity Likely > 1000 different bacterial species in the gut Inflamm. Bowel Dis 2004; Science 2005; 308:1635-38; Physiol Rev 2010;90:859-904; Gastroenterology 2014;146:1449-58

  6. BACTERIA IN YOUR GUT What do they do? Produce carbohydrate-active enzymes that digest carbohydrates Break down protein to their component amino acids and then participate in their change to biogenic amines (compounds with another effect on the body), to immunomodulator compounds and to signaling compounds. Produce antimicrobial peptides or bacteriocins that may keep harmful organisms at bay. Make vitamins such as folate and Vitamin B12 Participate in and stimulate the development and function of the immune response Inflamm. Bowel Dis 2004; Science 2005; 308:1635-38; Physiol Rev 2010;90:859-904; Gastroenterology 2014;146:1449-58

  7. BACTERIA IN YOUR GUT ESOPHAGUS (0-102) Limited in diversity Dominated by Streptococcus Increased diversity associated with chronic inflammation and dysplasia STOMACH (0-102) Limited in diversity Helicobacter pylori limits diversity Without H. pylori dominated by Streptococcus SMALL INTESTINE (102duodenum, jejunum; 107-108 distal ileum) Dominated by Streptococcus in duodenum and jejunum Increased number and diversity as you travel down the small bowel to the ileum Gastroenterology 2014;146:1449-1458

  8. BACTERIA IN YOUR GUT LARGE INTESTINE (COLON) (1011-1012) Dominated by phylum Firmicutes (includes Lactobacilli) and phylum Bacteroidetes Next most common Actinobacteria (includes Bifidobacteria) and Verrucomicrobia Diet can change the microbiome Ratio of Firmicutes: Bacteroidetes may determine predisposition to obesity Proteobacteria small proportion in normal individuals but may be increased in people with GI diseases Gastroenterology 2014;146:1449-1458

  9. CELIAC DISEASE AND IRRITABLE BOWEL SYNDROME What is the possible connection? Symptoms of celiac disease and IBS may overlap People with celiac disease may also have IBS Studies show a 4.5% prevalence of celiac disease in people with IBS diagnosed by Rome I or II criteria Systemic review and meta-analysis showed 4 fold increase in IBS compared to non-IBS populations of celiac disease with positive serology and biopsies 3% of people with a clinical presentation of IBS subsequently diagnosed with celiac disease. Reviewed in Verdu EF et al. Am J Gastroenterol 2009. 104(6):1587-94

  10. IRRITABLE BOWEL SYNDROME Can present as: 1. Diarrhea predominant (IBS-D) 2. Constipation predominant (IBS-C) 3. Mixed (alternating pattern of diarrhea and constipation)

  11. IRRITABLE BOWEL SYNDROME Criteria for Diagnosis Rome I >3 months (continuous or recurrent) Rome II >3 months in the last 12 months (does not need to be consecutive) Abdominal pain (continuous or recurrent) in the last year associated with 2 or 3 of the following: Rome III >3 days in the last 3 months (onset at least 6 months prior to diagnosis) Recurrent abdominal pain associated with 2 or more of the following: Timing Criteria Abdominal pain (continuous or recurrent) relieved with defecation or associated with change in stool frequency with 2 of the following at least 25% of days: 1. Improvement with defecation 2. Onset associated with change of stool form 3. Onset associated with change of stool frequency 1. Relieved with defecation 2. Onset associated with change of stool form 3. Onset associated with change of stool consistency 1. Altered stool frequency 2. Altered stool form/passage 3. Passage of mucus 4. Bloating or feeling of abdominal distension

  12. The microbiome (gut bacteria composition) is altered in IBS Bifidobacterium--decreased Lactobacillus-inconsistent findings with some studies showing a decrease and others showing an increase

  13. The microbiome (gut bacteria composition) is altered in Celiac Disease (CD) Reduced concentration of Bifidobacterium spp. in the feces of untreated CD patients and in both active and nonactive CD as compared to healthy people Decreased numbers of Bifidobacterium spp. and increased numbers of Bacteroides spp. In duodenal biopsies of untreated CD Treated CD patients with persistent symptoms vs those without symptoms had higher relative abundance of Proteobacteria and lower numbers of Bacteroidetes and Firmicutes with an overall reduction in microbial richness J Clin Gastroenterol 2013:47;101-103; j Clin Pathol 2009;62:264-9; Am J Gastroenterol 2014:109;1933-1941

  14. WHAT ARE PROBIOTICS Probiotics are living organisms contained in foods, such as yoghurt, and in other supplements in the form of capsules, powder or tablets, which confer a health benefit when administered in adequate amounts. Morelli L. J Clin Gastroenterol 2012;46:S1-S2

  15. Some Probiotics on the Market 27388_582787_1166632032

  16. Some Probiotics on the Market B. lactis Bb12 L. rhamnosus GG L. casei Shirota L. casei L. casei L. reuteri L. johnsonii

  17. PROBIOTICS IN IBS Mechanisms of action Change gut bacterial composition Potentially return abnormal gut flora to normal Competitive interactions with pathogens Produce chemical products, that are toxic to pathogenic bacteria or viruses. Reinforce the mucosal barrier Inhibit the movement of bacteria across the gut wall Produce neurotransmitters that influence the motility and sensation of the gut Produce cytokines, neuroactive peptides, fatty acids, gas and other substances. Reviewed in Gastroenterology 2014; 146 (6)

  18. Probiotics Effective in IBS Probiotic Bifidobacterium animalis Targeted Symptom relief Reduced discomfort and bloating in constipation-predominant IBS Sample Size 274 Weeks 3/6 Bifidobacterium infantis 35624 Reduced abdominal pain and other IBS symptoms 362 4 Bifidobacterium bifidum MIMBb75 IBS symptoms and QOL Alleviated global IBS, improved 122 4 Escherichia coli Nissle Helped in patients with altered enteric microflora, for example, after gastroenterocolitis or use of antibiotics 120 12 Lactobacillus plantarum 299v Improved abdominal pain and bloating 214 4 Reviewed in S.S Magge & J.L Wolf . Women s Health (2013) 9(6), 1-11

  19. Probiotics Effective in IBS Probiotic Targeted Symptom relief Improved QOL, but not significantly in individual symptoms Sample Size 67 Weeks Saccharomyces boulardii 4 Lactobacillus Acidophilus NCFM Improved bloating 60 4 Bifidobacterium lactis Bi-07 Improved bloating 60 4 Lactobacillus Rhamnosus GG Reduced frequency and severity of abdominal pain in children 50 6 Lactobacillus acidophilus Reduced abdominal pain 40 4 VSL#3 colonic transit Reduced flatulence and retarded 48 4/8 Reviewed in S.S Magge & J.L Wolf . Women s Health (2013) 9(6), 1-11

  20. PROBIOTICS IN CELIAC DISEASE VSL#3 (but not 3 other probiotics) reduced the toxicity of gluten when used in a fermentation process Bifidobacterial strains produced less toxic gliadin peptides in vitro Saccharomyces boulardii KK1 degraded part of the - gliadin. In gluten sensitized mice KK1 decreased the IgA transporter (CD71) and improved the small bowel abnormalities and local cytokines (accelerated hair loss with DC412) Bifidobacterium infantis Natren Live Start Super Strain did not improve intestinal permeability, but did improve Gastrointestinal Symptoms and a macrophage inflammatory cytokine, but not other inflammatory markers (# 12 CD; 10 controls) Biochimica et Biophysica Acta 2006; 1762:80-93; Laboratory Investigation 2012;92:625-635J Clin Gastroenterol 2013:47;101-103;

  21. Mouse Model for Celiac Disease: Treatment with probiotics Gluten Diet (G+) Sacrifice D7 D1 D37 G-mice Every Day Every 3 days Oral delivery of KK1 or DC205 or DC412 or PBS Laboratory Investigation 2012;92:625-635

  22. Mouse Model for Celiac Disease: Treatment with probiotics Villous:crypt ratio G- No gluten G+ With gluten KK1 Saccharomyces boulardii DC205, DC412 Lactobacillus paracasei *P<0.05 G + to G-, #P<0.05 KK1 to G+ * * * # * Laboratory Investigation 2012;92:625-635

  23. Mouse Model for Celiac Disease: Treatment with probiotics Positive Cell number * # * * * * * * * *** # * * # * * * ** * * * * * * ** *P<0.05 G + to G-, #P<0.05 KK1 to G+ Laboratory Investigation 2012;92:625-635

  24. Treatment of Celiac Disease with Bifidobacterium infantis Probiotic Arm (#) Baseline Final Placebo Arm (#) Baseline Syndromes Final Indigestion 4.6) 4.3 (3.4-5.3) 2.9 (2.1-3.7)* 4.0 (2.7-5.3) 3.6 (2.6- Diarrhea 2.3)* 3.3 (2.0-4.7) 2.7 (1.6-3.8) 2.9 (1.7-4.0) 1.6 (0.9- Constipation 3.7) 3.6 (2.2-5.0) 2.5 (1.4-3.5)^ 2.7 (1.5-3.9) 2.4 (1.0- GERD Not Significant Not Significant Abdominal Pain Not Significant Not Significant Composite Score Final/baseline ratio *P <0.005, ^P<0.05 Not Significant Not Significant E. Smecuol et al. J Clin Gastroenterol 2013:47;139-147

  25. Herbal medicines shown to be effective in IBS Herbal medicines use plant extracts to treat different symptoms and diseases. For effective results the herbs can be used either individually, as a mixture of different herbs or in combination with western medication. Herbal Medicine Study (Wks) Targeted Symptom Relief Length of Chinese Herbs Improved IBS global symptoms 16 Padma Lax Improved constipation, abdominal pain, abdominal distension and flatulence 12 Tong Xie Yao Fang Decrease in activated mast cells present in IBS 4 STW5,STW5II,placebo STW 5/placebo (315) Reduced abdominal painand IBS symptoms Decreased gastrointestinal symptom score 4 8 Reviewed in S.S Magge and J.L Wolf. Women s Health (2013) 9(6), 1-11

  26. The truth about gas When carbohydrates and fat within our food aren t broken down by the enzymes our bodies make and are not absorbed by the intestines into our bodies, bacteria found in our bowels metabolize them and form gas as a by-product. Depending on the type of bacteria residing in your gut and what food you eat, different gases and therefore different odors will be released. Gas is often a byproduct of what we eat.

  27. TREATMENT OF GAS AND BLOATING Peppermint oil Simethicone-changes the surface characteristics of the gas bubbles making it easier to pass Activated charcoal-adsorbs the gas. However, it can interfere with medication absorption

  28. Peppermint Oil: Treatment for Gas and Bloating A cross between watermint and spearmint Menthol is thought to be the active component causing calcium-channel blocking activity The blockage of calcium flow into smooth muscle in the intestine decreases muscle contractions thereby reducing pain Adverse effects include heartburn, skin rash, perianal burning, bradycardia and muscle tremor. Reviewed in S.S Magge and J.L Wolf .Women s Health (2013) 9(6), 1-11

  29. Peppermint Oil in IBS Study Size Targeted Relief Symptom Sample Meta-analysis of 8 Trials-5 dble blind Significant improvement of IBS symptoms Randomized, Double-blind placebo stool frequency and flatulence Controlled study-4wks Reduced abdominal distension,, 110 2007 Double-blind study 4 weeks 75%PO vs 38%PL >50% reduction in IBS symptoms 57IBS Reviewed in S.S Magge and J.L Wolf .Women s Health (2013) 9(6), 1-11

  30. Acupuncture not shown to be effective in IBS Acupuncture is based on a life force qi that runs through the body in channels called meridians Disruptions in qi result in disease processes, which can be corrected at the exact anatomical locations using acupuncture Study Real vs Sham acupuncture vs no treatment Cochran review-17 random- Many poor quality. Ized clinical trials Results Sample Size/wks No significant difference in IBS symptoms sham vs real but better than no treatment 230/3 wks 1806/variable Variable results.Same as Bifidobacteria, psychotherapy Reviewed in S. S Magge et al. Women s Health 2013. 9(6):1-11

  31. SUMMARY The gut contains numerous bacteria The bacteria differ in people with Irritable Bowel Syndrome (IBS) and Celiac disease (CD) from healthy individuals without those conditions. Some probiotics have been shown to improve symptoms of patients with IBS Some probiotics make gluten less toxic to patients with CD, but to date in people in contrast to animals there are no trials showing benefit. Some herbal compounds help IBS patients Peppermint oil may help bloating and gas Acupuncture has not shown benefit in IBS

More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#